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  A  cross-sectional  study  with  a  random  cluster  sampling  design  was  carried  out  to 
estimate the seroprevalence of bovine herpesvirus type 1 (BHV-1) in non-vaccinated dairy 
herds in Hamedan province, west of Iran. Simple random sampling was used for selection of 
cattle in each herd. Informative data about each herd and selected animals were recorded by 
the  farm  manager  in  a  provided  questionnaire.  Blood  samples  were  collected  from  492 
animals in 41 industrial herds. A commercial indirect ELISA test was used to determine the 
seropositivity  against  BHV-1.  The  individual  and  herd  seroprevalence  for  BHV-1  were 
58.74% and 82.93%, respectively. The intra-herd prevalences were ranged from 16.70% to 
100%.  Geographical  characteristics  of  Hamedan  province  may  explain  the  high  sero-
prevalence rates found in this study compared to those of others obtained from different 
parts of the country. The proportion of seropositive cows were increased with age (p <0.05). 
Animals from large and moderate sized herds had higher odds of seropositivity than those of 
small size herds. These findings could be related to the presence of a considerable number of 
BHV-1 carriers in this region. The high herd and animal prevalence found in the present 
study suggested necessity of implementing an intensive control program for reducing BHV-1 
infection rates. 
© 2013 Urmia University. All rights reserved. 
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پ׌ت ׌واگ سور׌و سپره اب ׌گدولآ ֩׌ژولورس هعلاطم   ֩׌   ( BHV-1  ) واگ رد  ׌راد نادمه ناتسا ׌ر׌ش ׌اه - ر׌ا نا  
 هد׌֩چ  
 پ׌ت ׌واگ سور׌و سپره اب ׌گدولآ ׌مرس عو׌ش ن׌مخت ׌ارب ׌فداصت ׌ا هشوخ ׌ر׌گ هنومن ׌حارط اب ׌عطقم هعلاطم ֩׌ ֩׌    هدشن هن׌س֩او ׌ر׌ش ׌اهواگ رد  رد  ناتسا ׌تعنص ׌اه ׌رادواگ
هلگ ره رد .دش ماجنا نار׌ا برغ رد نادمه ،   تاعلاطا .دندش باختنا هداس ׌فداصت تروص هب اهواگ    زا .دش تبث ׌ا همانشسرپ رد و ذخا ׌رادواگ ر׌دم زا هدش ׌ر׌گ هنومن ׌اهواگ و اه هلگ هب طوبرم
294    هب طوبرم واگ سأر 24   ره ׌ا هلگ و ׌دارفنا ׌مرس عو׌ش .د׌درگ هدافتسا م׌قتسمر׌غ ׌از׌لاا ׌تراجت ت׌֩ زا مرس ׌اه هنومن ش׌امزآ ׌ارب .دش ه׌هت نوخ هنومن هلگ  پ׌ت ׌واگ سور׌و سپ ֩׌    هب
 ب׌ترت 42 / 85    و دصرد 99 / 54    زا ز׌ن ׌ا هلگ لخاد عو׌ش .دوب دصرد 4 / 41    ات 411    ن׌ا رد هدمآ تسدب ׌مرس عو׌ش ׌لااب ناز׌م هدنن֩ ه׌جوت دناوت ׌م نادمه ناتسا ׌ئا׌فارغج ׌گ֘׌و .دوب ر׌غتم دصرد
ب ،تبثم مرس ׌اهواگ تبسن .دشاب روش֩ قطانم ر׌اس ׌اه هتفا׌ اب هس׌اقم رد هعلاطم ( تفا׌ ش׌ازفا نس نتفر لااب ا 18 / 1   > p   ׌اه هلگ زا ش׌ب طسوتم و گرزب ׌اه هلگ رد اهواگ ندش تبثم مرس سناش .)
هتفا׌ ن׌ا .دوب ֩چو֩ ׌م اه  پ׌ت ׌واگ سور׌و سپره ׌اه لماح هجوت لباق دادعت روضح هب دناوت ֩׌   ن׌ا رد ׌دارفنا و ׌ا هلگ ׌لااب عو׌ش .دشاب هتشاد طابترا هقطنم ن׌ا رد    هن׌داهن ترورض ،هعلاطم
پ׌ت ׌واگ سور׌و سپره اب ׌گدولآ ناز׌م شها֩ ׌ارب ار هدرشف ׌لرتن֩ همانرب ֩׌ ندر֩   ֩׌   ׌م داهنش׌پ .دن֩  
:׌د׌ل֩ ׌اه هژاو   پ׌ت ׌واگ سور׌و سپره ،׌ر׌ش واگ ،نار׌ا ،از׌لاا   ֩׌ نادمه ،  
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Introduction 
 
Infectious bovine rhinotracheitis/infectious pustular 
vulvovaginitis (IBR/IPV), caused by bovine herpes virus 
type 1 (BHV-1), is an important disease of domestic and 
wild  cattle.1  Clinical  signs  of  BHV-1  infection  include 
symptoms of inflammatory reactions in both respiratory 
and  genital  tracts,  and  abortion.  A  systemic  disease 
affecting visceral organs may develop in young calves.2 
BHV-1 is a member of genus Varicellovirus in the subfamily 
Alphaherpesvirinae, which belongs to the Herpesviridae 
family. However, there is only one antigenic serotype 
of  BHV-1  by  conventional  serological  assays.3  Two 
subtypes of BHV-1.1 (respiratory subtype) and BHV-1.2 
(respiratory and genital subtype) have been described 
for  this  virus,  based  on  restriction  enzyme  cleavage 
patterns of viral DNA.1  
The BHV-1 infection is mainly transmitted via respiratory, 
ocular  or  genital  secretions  through  direct  contact 
between animals. However, the infection may also spread 
via fresh or frozen semen from infected bulls as well as 
contaminated equipments.1 Following a primary infection 
with a field isolate or vaccination with an attenuated strain, 
BHV-1  can  become latent.  The  latent BHV-1  infection  can 
become  reactivated  and  the  animal  may  shed  the  virus 
following stimuli, for example transport, parturition and 
glucocorticoid therapy.4  
BHV-1  infections  can  be  diagnosed  by  serological 
tests  that  detect  the  virus,  viral  antigen  or  specific 
antibody  and  by  nucleic  acid-based  tests  that  detect 
genomic DNA, nucleic acid hybridization and sequencing. 
The  immune  response  to  primary  BHV-1  infection  in 
experimentally  infected  cattle  is  characterized  by  the 
development of specific IgM and IgG antibodies at 7 days 
post  inoculation.  Bovine  herpes  virus  type  1  infected 
cows  are  mainly  detected  by  the  presence  of  specific 
antibodies  to  the  virus  after  acute  phase  and  during 
latency.  Both  virus  neutralization  (VN)  test  and  ELISA 
have  been  employed  for  detecting  antibodies  against 
BHV-1. The ELISA is a specific, sensitive and practical test 
for detection of antibodies and has advantages over the 
VN test.5,6 Moreover, several types of BHV-1 ELISA tests 
are commercially available and some of them can be used 
in conjugation  with  marker vaccines  to  detect  infected 
cattle in vaccinated populations.6-8  
The  detection  of  latent  BHV-l  infection  in  cattle  is 
important  for  control  programs  and  trade  activities  in 
dairy farms. Several studies have already demonstrated 
large different seroprevalence from 22.68% in the south9 
to  48.90%  in  the  northwest  of  Iran.10  There  is  no 
published  data  on  BHV-1  prevalence  in  dairy  herds 
located in western provinces of Iran. Therefore, the main 
purpose  of  the  present  study  was  to  determine  the 
seroprevalence of BHV-1 infection in dairy cattle herds of 
Hamedan province, Iran. 
 
 
  Materials and Methods 
 
Study design. A cross-sectional study, with a random 
cluster sampling design, carried out in 41 industrial dairy 
herds  of  Hamedan  province  (situated  in  the  middle  of 
western Iran) between June and August 2009. The study 
area lies between longitudes 47˚ 34´ to 49˚ 36´ E and latitudes 
33˚ 59´ to 35˚ 48´ N. Hamadan province is located in a temperate 
mountainous  region  with  mean  annual  precipitation  of 
330  mm  and  mean  annual  temperature  is  11.4  ˚C.  The 
populations of cows in the tested farms were 50 to 660. 
Before sampling, the herds were divided to small (50-100 
cows), medium (100-400 cows) and large (> 400 cows) units. 
No vaccination against BHV-1 was carried out in the farms; 
however, artificial insemination was applied in most of those 
herds. In each selected farm, individual cattle were chosen by 
random sampling method. The tested animals were divided 
to group A (between 6 months and 2 years), B (between 2 
and 3 years), C (between 3 and 4 years) and D (more than 
4 years), in order to study the association of age with sero-
prevalence of the virus. To avoid false positive results due 
to  potentially  presence  of  maternal  antibodies,  calves 
younger than six months age were excluded from the study.  
Serological  test.  Four  hundred  ninety  two  blood 
samples  were  collected  from  coccygeal  vein  using  plain 
vacutainer tubes, and transferred to the laboratory on ice. 
The  samples  were  centrifuged  at  2000  g  for  10  min  to 
obtain serum. Sera were stored in the labeled microtubes 
at -20 ˚C until analyzed. BHV-1 specific antibodies in the 
serum  samples  were  detected  using  bovine  rhino-
tracheitis  virus  (BHV-1)  gE  antibody  ELISA  test  kit 
(HerdCheck® IDEXX Laboratories, Inc., The Netherlands) 
according  to  manufacturer's  instruction.  Optic  density 
(OD) was read at 650 nm in a multi-well plate reader 
(ELX 800, BioTek Inc., Winooski, VT, USA). According to the 
manufacturer, the sensitivity and specificity of the kit was 
98.00%.  The  Serum  samples  with  OD  ≥  0.50  were 
considered as positive cases.  
Data analysis. Considering the reported specificity of 
the used kit (98.00%), herd with zero or one seropositive 
animals was defined as negative and herds with at least 2 
seropositive  animal  as  positive.  Herd  size,  within-herd 
prevalence, overall individual and herd prevalence were 
calculated on the basis of the number of tested animals. 
Data analysis of Chi-Square and Fisher's exact test were 
carried out by SPSS version 16.0 (SPSS Inc., Chicago, IL, 
USA).  A  p  value  of  less  than  0.05  was  considered 
statistically significant. 
 
Results 
 
Seroprevalence of BHV-1 antibody in sampled animals 
was found to be 58.74% (289 of 492 sera) and according 
to presence of at least 2 seropositive animals in a herd, 34 
herds (82.93%) were seropositive (Table 1). 113  A. Bahari et al. Veterinary Research Forum. 2013; 4 (2) 111 - 114 
 
 
 
 
 
 
 
 
 
 
 
The  prevalence  was  ranged  from  16.70  to  100% 
among seropositive herds in this study. All of 7 (17.10%) 
negative herds were from small and medium size herds 
(Table 1). Seroprevalence of BHV-1 within age groups was 
increased with age (Table 2). Based on age, the prevalence 
of seropositivity among group A was significantly different 
from  other  groups  (p  <  0.05).  However,  the  prevalence 
rates  between  age  groups  of  B,  C  and  D  showed  no 
significant differences (Table 2).  
 
 
 
 
 
 
 
 
 
 
Discussion 
 
The seroprevalence of BHV-1 in tested herds (82.93%) 
and tested animals (58.74%) found in this cross-sectional 
study  was  more  than  previously  reported  studies. 
Serological studies on the dairy cattle of different parts of 
Iran demonstrated 22.68% infection in Shiraz,9 30.39% in 
Kerman,11 31.48% in Ahvaz,12 46.68% in Chaharmahal and 
Bakhtiari province13 and 48.9% in Urmia.10 It is reported 
that farms located in colder and higher altitude area are 
more  prone  to  have  experienced  BHV  infections.14  The 
climate and/or dairy cattle practice density in regions with 
higher prevalence is almost similar to Hamedan province 
from  which  obtained  results  were  also  similar.  On  the 
other hand, industrial dairy herd farming is not a common 
practice  in  low  altitude  areas  of  Iran  which  are  often 
tropical and dry. The geographical variations may explain 
the differences  between our results and low prevalence 
areas  such  as  Shiraz,  Kerman  and  Ahvaz.  Infection 
prevalences  in  small  herds  are  significantly  less  than 
moderate and large ones (Table 1). In our opinion, beside to 
lower natural exposure in small herds, biosecurity programs 
might  be  better  implemented  than  moderate  and  large 
herds. The herd and animal BHV-1 prevalence in the current 
study  did  not  differ  greatly  with  those  reported  from 
countries that have no control program for BHV-1 infection.  
  The  prevalence  rates  were  84.00%  for  dairy  herds  and 
35.00% for dairy cows in Belgium,15 50.0% in Germany,16 
80% for Hungary17 before start of their eradication programs 
and 61.00% in unvaccinated dairy herds of Italy.18 In 107 
non-vaccinated  herds  in  south  west  of  England,  mean 
seroprevalence  of  cattle  and  herds  have  been  detected 
42.50% and 43.00%, respectively.14 Considering herd size 
and management systems of dairy herds in each region or 
country, all the mentioned studies reported a moderate to 
high prevalence of infection prior to beginning an eradication 
program which may reflect the latency ability of the virus. 
All breeds of cattle at any age are susceptible but the 
disease occurs most commonly in animals over 6 months 
old, probably because of their greater exposure (e.g. nasal 
exudate  and  coughed-up  droplets,  genital  secretions, 
semen,  fetal  fluids  and  tissues  and  etc.)  to  the  infective 
agent and loss maternal immunity.19 There was a positive 
relationship  between  age  and  proportion  of  seropositive 
cows  in  the  present  study.  Similar  findings  were  also 
reported  by  Boelaert  et  al.15  and  Solis-Calderon  et  al.20 
Since vaccination against BHV-1 was not practiced in the 
tested  dairy  herds,  seropositivity  was  probably  due  to 
their naturally greater exposure to the virus. This fact is 
clearly  demonstrated  by  significant  difference  between 
group A and other age groups (Table 2). Antibodies against 
BHV-1 persist throughout the animal's life after a natural 
infection.1 Moreover, the older animals are more likely to 
be exposed to natural sources of infection.21 Badiei et al. 
did not find any difference in the number of seropositive 
cows  between  age  groups.9  They  explained  that  their 
unexpectedly findings might be due to difference in herd 
size, cow rearing systems and animal keeping conditions. 
Serologically  positive  cows  which  are  latent  carriers 
have the key roles in reserving and transmission of BHV-1 
to susceptible animals.22 In agreement with Boelaert et al. 
and Solis-Calderon et al. the prevalence rate higher than 
38.00% (Table 1) may indicate the naturally circulation of 
BHV-1 among animals.15,20 Moreover, the largest herds and 
older animals had highest seropositivity (Tables 1 and 2). 
This may show a high number of BHV-1 carriers in this herds.  
The  method  of  isolation  and  slaughter  of  seropositive 
animals based on Danish and Swedish IBR control programs 
is inefficient for eradication of infection in countries with 
large herds or high seroprevalence of BHV-1. Several European 
countries  have  initiated  control  programs  for  eradication 
purposes  based  on  using  inactivated  or  live  attenuated 
marker  vaccines  but  no  vaccine  is  able  to  prevent  the 
infection and the establishment of latency.23,24 The marker 
vaccines  used  together  with  a  serological  detection  of 
glycoprotein E-specific antibodies, allow differentiation of 
naturally infected cows from vaccinated animals.25 
In conclusion, the high prevalence in herds and animals 
found  in  this  study  suggested  necessity  of  an  intensive 
control program for reducing BHV-1 infection rates. Based 
on present findings, we recommend using marker vaccine  
Table  1.  Seroprevalence  of  BHV-1  within  examined  herds  and 
tested dairy cattle in Hamedan province, Iran (%). 
Herd 
size* 
No. of 
herds 
No. of  sero-
positive herds 
No. of 
samples 
No. of  sero-
positives † 
No.  of  sero-
negatives † 
Small  18  14   216   104 (48.15) a  112 (51.85) a 
Medium     18  15   216   139 (64.35) b  77 (35.65) b 
Large   5  5   60   46 (76.67)  b  14 (23.33) b 
Total  41  34   492   289 (58.74)  203 (41.26) 
* Small: 50-100, medium: 100-400, large: > 400 dairy cows in herd. 
† In each column, different letters show significant difference (p < 0.05). 
Table 2. Distribution of BHV-1 seroprevalence in dairy cattle with 
different ages of Hamedan province, Iran (%). 
Groups               Age  No. of 
samples 
No. of sero-
positives * 
No. of sero-
negatives * 
A                6 months to 2 years  55  21 (38.18) a  34 (61.82) a 
B  2 to 3 years  113  60 (53.10) b  53 (46.90) b 
C  3 to 4 years  147  93 (63.27) b  54 (36.73) b 
D  more than 4 years  177  115 (64.97) b  62 (35.03) b 
  Total  492  289 (58.74)  203 (41.26) 
* In each column, different letters show significant difference (p < 0.05). 114 
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and serologically differentiation of naturally infected cows 
from  vaccinated  animals  for  eradication  of  IBR/IPV. 
Planned biosecurity measures are needed to control the 
epidemiological  risk  of  infection  due  to  the  presence  of 
BHV-1 latent carriers. 
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